Literature DB >> 8437718

Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes.

A H Moss1, P Casey, C B Stocking, R P Roos, B R Brooks, M Siegler.   

Abstract

We conducted this study to better inform amyotrophic lateral sclerosis (ALS) patients about home ventilation and to assist them in decision-making. We gathered data on the prevalence of ALS patients on home ventilation in northern Illinois and the percentage who chose it, and we asked identified subjects, their families, and physicians for their attitudes toward home ventilation. Fewer than 10% of ALS patients had chosen home ventilation, and fewer than 5% were still on it. Seventeen patients (90%) were glad to have chosen home ventilation and would choose it again. Family caregivers reported major burdens, and only half would choose it for themselves. The mean yearly cost of home ventilation was $153,252. Home ventilation is effective for ALS patients had desired by the small number who undergo it, but it imposes significant burdens on families.

Entities:  

Mesh:

Year:  1993        PMID: 8437718     DOI: 10.1212/wnl.43.2.438

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Rationale for the use of non-invasive ventilation in chronic ventilatory failure.

Authors:  P M Turkington; M W Elliott
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 2.  Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease.

Authors:  M I Polkey; R A Lyall; A C Davidson; P N Leigh; J Moxham
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 3.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

4.  Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline.

Authors:  Douglas A McKim; Jeremy Road; Monica Avendano; Steve Abdool; Fabien Cote; Nigel Duguid; Janet Fraser; Fracois Maltais; Debra L Morrison; Colleen O'Connell; Basil J Petrof; Karen Rimmer; Robert Skomro
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

5.  Motor neurone disease.

Authors:  J M Shneerson
Journal:  BMJ       Date:  1996-08-03

Review 6.  Impact of riluzole on the relationship between patient and physician.

Authors:  R Dengler; M Tröger
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

7.  The economic burden of amyotrophic lateral sclerosis: a systematic review.

Authors:  K Achtert; L Kerkemeyer
Journal:  Eur J Health Econ       Date:  2021-06-18

Review 8.  Motor neuron disease.

Authors:  P N Leigh; K Ray-Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

9.  Family caregiver perspectives on caring for ventilator-assisted individuals at home.

Authors:  Rachel Evans; Michael A Catapano; Dina Brooks; Roger S Goldstein; Monica Avendano
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

10.  Depression and quality of life in patients with amyotrophic lateral sclerosis.

Authors:  Dorothée Lulé; Sonja Häcker; Albert Ludolph; Niels Birbaumer; Andrea Kübler
Journal:  Dtsch Arztebl Int       Date:  2008-06-06       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.